The Iranian anti-rheumatic drug market comprises a strategic segment of the national pharmaceutical sector, focused on the management of chronic autoimmune and inflammatory musculoskeletal disorders. The core product categories include non-...
...
The Duchenne Muscular Dystrophy (DMD) pipeline analysis market encompasses the specialized sector of drug development, clinical evaluation, and regulatory navigation for therapies targeting the DMD gene and its protein product, dystrophin. ...
Merkel Cell Carcinoma Pipeline Analysis Market Size: The Merkel Cell Carcinoma Pipeline Analysis Market is projected to grow significantly during the forecast period (2025-2030). Merkel Cell Carcinoma Pipeline Analysis Market Key High...
Gabapentin Market Size: The gabapentin market is estimated to grow at a CAGR of 3.82% during the forecast period. Gabapentin Market Key Highlights Generic Dominance and Price Erosion: The market is overwhelmingly dominated by the g...
The Cannabis Market is expected to grow from US$59.603 billion in 2025 to US$132.935 billion in 2030, at a CAGR of 17.40%. Cannabis is a psychoactive substance extracted from the cannabis plant which is native to Central and South Asia. It...
Nanomedicine Market, sustaining a 10.22% CAGR, is projected to expand to USD 442.631 billion by 2030 from USD 272.056 billion in 2025. The medical application of nanotechnology is the focus of the interdisciplinary field of nanomedicine. N...
The acne treatment market is estimated to attain a market size of USD 17.380 billion by 2030, growing at a 4.81% CAGR from a valuation of USD 13.739 billion in 2025. Acne Treatment Market Introduction This market is driven by diverse ther...
The human insulin market is expected to grow at a CAGR of 3.28%, reaching a market size of US$27,421.71 million in 2030 from US$23,334.45 million in 2025. Insulin is the hormone that controls sugar levels in the body. Diabetes is a chronic...
Genomic Medicine Market is expected to grow at a CAGR of 20.61% from a market size of US$15.91 billion in 2022 to reach US$59.07 billion in 2029. Genomic medicine is changing healthcare. By analyzing an individual's genetic information, ge...
The global antipsychotic drugs market was valued at US$16.311 billion in 2022 and is projected to expand at a CAGR of 6.51% over the forecast period to reach US$25.358 billion by 2029. Antipsychotic medicines, commonly known as antipsychot...
The Middle East and Africa veterinary pharmaceuticals market is estimated to grow at a CAGR of 6.14%, reaching US$392.695 million in 2028 from US$258.827 million in 2021. The Middle East and Africa veterinary pharmaceuticals industry is exp...
Explore interconnected markets and cross-industry research.